BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug development company, announced today that it has appointed two executives to new positions on its senior management team. Dr. Srdjan (Serge) Stankovic, has joined Neurogen as Executive Vice President & Chief Development Officer. Dr. Stankovic joins Neurogen from Cephalon, Inc. where he was Vice President, Worldwide Clinical Research. Dr. Thomas Pitler, who has served as Neurogen’s Vice President, Business Development has taken on the expanded role of Senior Vice President & Chief Business and Financial Officer.
